Influenza Vaccine Clinical Trial
Official title:
Influenza 2020/2021. A Survey to Assess How People's Political Attitudes and Messages Influence Their Behavioral Intentions in the United Kingdom.
As part of the fight against COVID-19, the UK government has announced its most comprehensive
flu campaign to date
(https://www.gov.uk/government/news/most-comprehensive-flu-programme-in-uk-history-will-be-ro
lled-out-this-winter). This should not be surpising: every year NHS hospitals experience an
overwhelming number of influenza cases, and COVID-19 increases this concern. As in previous
years, the flu vaccine is free at the point of care for people 65 and over. New this year is
that later in the season the vaccine will be made available free at the point of care for
people 50 and over. However, if people refuse to take the vaccine this comprehensive program
cannot benefit public health.
The degree to which vaccine hesitancy is expressed varies across characteristics of the
vaccine considered and the time and place it is offered, and across characteristics of the
person's perceptions of complacency, convenience, confidence, calculations, and communal
responsibility, i.e. the "5Cs". Information campaigns can be used to influence all 5Cs, and
public facing information is often a necessary component of public health campaigns that may
also include structural components. Largely, information campaigns can be viewed as a type of
educational intervention.
Educational interventions may fall short of what is needed to alter people's intentions to
vaccinate where they focus on system 1 rational thinking processes and neglect system 2
automatic thinking processes. To be more effective, public health messages must be tailored
to align with the "beliefs, attitudes, and motivations" of the very people they intend to
influence.
Fact-led educational interventions to increase parents' intentions to vaccinate their
children are particularly ineffective where more subtle content opposes the recipient's
deep-seated values. In a different context, recycling behaviour, previous research
demonstrated that messages aligned with people's deep-seated values (i.e. the moral
foundations that underlie political ideologies) are more likely to promote desired
behavioural intentions than unaligned messages.
The present research expands the scope of previous research in two ways. First, rather than
investigating parental attitudes towards vaccination, the investigators will look at people's
intentions to self-vaccinate. Second, the investigators will explore the effectiveness of
messages aligned with the moral foundations that underlie individual's political ideologies
on their intentions to be vaccinated.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03285997 -
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
|
Phase 3 | |
Recruiting |
NCT05996549 -
Cost-effectiveness of the Influenza Vaccination
|
Phase 4 | |
Completed |
NCT05157425 -
Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination
|
N/A | |
Completed |
NCT01687517 -
Efficacy and Safety of Influenza Vaccine During Sarcoidosis
|
Phase 3 | |
Completed |
NCT01180699 -
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant Recipients
|
N/A | |
Completed |
NCT00760175 -
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients
|
N/A | |
Completed |
NCT00542776 -
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
|
N/A | |
Completed |
NCT06304038 -
Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome
|
||
Recruiting |
NCT04086628 -
Influenza Vaccine in Children With Asthma
|
||
Completed |
NCT02960815 -
Imiquimod and Influenza Vaccine for Immunocompromised Patients
|
Phase 2 | |
Completed |
NCT00828555 -
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
|
N/A | |
Completed |
NCT04230343 -
Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour
|
N/A | |
Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A | |
Completed |
NCT02153671 -
Immunogenicity of H5N1 Vaccine Following H5N2
|
Phase 2 | |
Completed |
NCT00461981 -
A Phase 2 Study to Evaluate Immune Responses of FluMist®
|
Phase 2 | |
Recruiting |
NCT05070494 -
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT04785794 -
Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
|
Phase 1 | |
Completed |
NCT05163847 -
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults
|
Phase 1 | |
Not yet recruiting |
NCT04355806 -
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
|
||
Completed |
NCT01368796 -
Comparison of 4 Influenza Vaccines in Seniors
|
Phase 4 |